Summary: Researchers have identified a specific long non-coding RNA gene, PTCHD1-AS, that influences the core behavioral traits of Autism Spectrum Disorder (ASD).
New research shows that deletions of this X-linked non-coding gene selectively affect social interaction and repetitive behaviors in males, while sparing cognitive abilities such as learning and memory. This discovery helps separate the biological pathways that produce the hallmark social and repetitive symptoms of autism from those that underlie broader developmental and cognitive functions.
Key Research Findings
- A non-coding regulator: PTCHD1-AS is a long non-coding RNA (lncRNA) that helps regulate other genes rather than encoding a protein. This sets it apart from the majority of known ASD-linked genes, which typically encode proteins.
- Behavioral specificity: Microdeletions affecting PTCHD1-AS on the X chromosome are associated with increased ASD risk in males. Male mice lacking the gene display heightened repetitive behaviors and altered social interactions, but normal learning, memory and attention.
- Striatal circuitry: The study localizes the gene’s primary effects to the striatum, a brain region critical for controlling repetitive actions and certain social behaviors.
- Synaptic plasticity and myelination: Loss of PTCHD1-AS alters synaptic plasticity—the brain’s ability to adapt signal strength—and changes markers of myelination, which affects how quickly signals travel between neurons.
- Protein kinase C involvement: The behavioral and synaptic changes were linked to reduced activity of conventional protein kinase C (cPKC) isoforms in a cortical-to-striatal circuit.
Source: Hospital for Sick Children
Overview: A previously underappreciated region of the human genome appears to play a distinct role in shaping the social and repetitive behaviors that characterize Autism Spectrum Disorder. Published in Nature, the study traces these core features to an X-linked long non-coding RNA, PTCHD1-AS, revealing a biologically specific mechanism that does not impair cognitive domains like learning or memory.
Led by researchers at The Hospital for Sick Children (SickKids), the study identifies PTCHD1-AS as an ASD susceptibility gene. The team found that deletions within this gene selectively alter social behavior and increase repetitive actions in males while leaving general cognition intact—an important distinction from other ASD genes that often cause a broader set of developmental problems.
Although genetic testing for ASD already includes about 100 genes or copy-number variants—most of which are protein-coding and linked to a range of developmental outcomes—PTCHD1-AS represents a different class of genetic risk: a regulatory non-coding RNA that targets specific neural circuits and behaviors. Pinpointing this separation between behavioral cores of ASD and broader cognitive impairments is crucial for developing targeted approaches to research and treatment.
A non-coding gene with a distinct role
Autism affects roughly one in 50 children and youth in Canada, with social and repetitive behaviors commonly shared across diagnoses. Long non-coding RNAs like PTCHD1-AS regulate gene expression and have been relatively unexplored in ASD research until now. The gene attracted attention because it lies near other protein-coding genes already implicated in autism and intellectual disability.
By analyzing whole-genome sequencing from more than 9,300 individuals with ASD and comparison data from controls, the researchers identified multiple X-chromosome deletions implicating PTCHD1-AS and showing increased ASD susceptibility in males—consistent with X-linked inheritance where males have only one X chromosome and no backup copy.
Mouse models developed by the team confirmed the human genetic findings. Male knockout mice that lack Ptchd1-as showed clear autism-like features—heightened repetitive behaviors and social interaction deficits—while performing normally on tasks measuring learning, memory and attention. This selective phenotype highlights a different biological mechanism compared with many protein-coding ASD models.
“PTCHD1-AS gives us a new entry point for studying the biology of ASD by linking a regulatory RNA to core autism traits,” says Dr. Stephen Scherer, senior author and senior scientist at SickKids. The gene’s specificity opens pathways to better understand how particular molecular changes produce distinct behavioral outcomes.
How PTCHD1-AS affects brain circuitry
To determine how PTCHD1-AS shapes behavior, the team examined brain tissue and circuit function in mouse models. Disrupting the gene altered synaptic plasticity within the dorsal striatum, a predominantly GABAergic region implicated in repetitive behaviors. These changes included shifts in gene and protein expression related to synaptic signaling and myelination—molecular signatures that point to altered circuit function.
Molecular analyses showed reduced levels of conventional protein kinase C isoforms and altered phosphorylation of signaling molecules such as SRC and GSK-3α/β. Electrophysiology revealed enhanced forms of striatal synaptic plasticity—both long-term potentiation (LTP) and long-term depression (LTD)—consistent with circuit-level dysregulation tied to behavioral outcomes.
“Combining human genetics, mouse models, multi-omics and electrophysiology allowed us to connect a non-coding gene with measurable changes in brain function,” notes co-author Dr. Graham Collingridge. The results provide a clear molecular and circuit-level framework linking PTCHD1-AS to core autism features.
Toward a more precise understanding of ASD biology
By associating a specific gene and molecular pathway with social and repetitive behaviors, the findings could have relevance across the autism spectrum, irrespective of additional clinical complexity. Identifying the pathways downstream of PTCHD1-AS—particularly those involving protein kinase C and synaptic plasticity—creates a targeted foundation for future research aimed at developing precision therapies directed at the core features of ASD.
Next steps include deeper investigation into the molecular, cellular and circuit-level mechanisms driven by PTCHD1-AS to pinpoint potential targets that could modify these core behavioral features. “This study underscores how modest changes in DNA regulation can shape complex human behavior,” adds Dr. Scherer.
Funding: The research was supported by Autism Speaks, Autism Science Foundation, Canada Foundation for Innovation, Canadian Institutes of Health Research, Genome Canada and Ontario Genomics, the Government of Ontario, Ontario Brain Institute, POND Network, Simons Foundation Autism Research Initiative, University of Toronto McLaughlin Centre and SickKids Foundation.
Key Questions Answered:
A: PTCHD1-AS is located on the X chromosome. Males have only one X chromosome, so a deletion in this gene directly impacts them. Females have two X chromosomes, and the second copy can often compensate for a deletion, reducing or preventing the effect.
A: PTCHD1-AS appears to regulate specific brain circuits—particularly within the striatum—that govern social and repetitive behaviors. Unlike many protein-coding ASD genes that broadly affect neural development and cognition, PTCHD1-AS selectively alters pathways tied to sociobehavioral traits while leaving learning and memory circuits intact.
A: While no clinical trials currently target the core features of ASD, tying PTCHD1-AS to a defined molecular pathway—especially involving protein kinase C and synaptic plasticity—provides a focused direction for developing potential precision therapies in the future.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The primary journal paper was reviewed in full.
- Additional context was added by editorial staff.
About this genetics and autism research news
Author: Jelena Djurkic
Source: Hospital for Sick Children
Contact: Jelena Djurkic – Hospital for Sick Children
Image: The image is credited to Neuroscience News
Original Research: Open access.
Title: “An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.”
Journal: Nature
DOI: 10.1038/s41586-026-10515-6
Abstract
An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism
Current genetic testing for ASD includes roughly 100 genes or copy-number variants, most of which are protein-coding and associated with broad phenotypes that extend beyond sociobehavioral traits. In a large whole-genome sequencing analysis of cases (9,349) and controls (8,332), 27 male individuals with ASD were identified with X-chromosome microdeletions implicating PTCHD1-AS as an ASD susceptibility gene (odds ratio = 2.56, P = 0.01).
Two Ptchd1-as knockout mouse lines—both disrupting a conserved exon—displayed autism-like features in male mice, specifically increased repetitive behaviors and impaired social behavior and communication, without cognitive comorbidities or ADHD-like traits. Hippocampus-dependent synaptic function, complex learning and locomotion were preserved in knockout mice.
Ptchd1-as expression in mice is nuclear-enriched and sustained from postnatal day 7 onward in the dorsal striatum, a GABAergic region implicated in ASD. Multi-omics analyses revealed transcriptomic changes in striatal oligodendrocytes, astrocytes and neurons affecting myelination and synaptic plasticity. Disruption of Ptchd1-as reduced conventional PKC isoforms, altered SRC and GSK-3α/β phosphorylation, and enhanced striatal LTP and LTD. Collectively, these data implicate striatal molecular and circuit-level dysregulation via PTCHD1-AS in ASD etiology.